HUP0203278A2 - Új berendezés és eljárás kristályos részecskék előállítására - Google Patents

Új berendezés és eljárás kristályos részecskék előállítására

Info

Publication number
HUP0203278A2
HUP0203278A2 HU0203278A HUP0203278A HUP0203278A2 HU P0203278 A2 HUP0203278 A2 HU P0203278A2 HU 0203278 A HU0203278 A HU 0203278A HU P0203278 A HUP0203278 A HU P0203278A HU P0203278 A2 HUP0203278 A2 HU P0203278A2
Authority
HU
Hungary
Prior art keywords
crystalline particles
substance
liquid
stream
solvent
Prior art date
Application number
HU0203278A
Other languages
English (en)
Inventor
Alan Ronald Ferrie
Andrew Patrick Savage
Original Assignee
Glaxo Group Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd. filed Critical Glaxo Group Ltd.
Publication of HUP0203278A2 publication Critical patent/HUP0203278A2/hu
Publication of HUP0203278A3 publication Critical patent/HUP0203278A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0059—General arrangements of crystallisation plant, e.g. flow sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10—Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány tárgya eljárás inhalációs terápiában alkalmazható anyagkristályos részecskéinek előállítására. A találmányt az jellemzi, hogyaz anyag folyékony oldószerben készült oldatának áramát és az említettanyag folyékony anti-oldószerének áramát, amely a folyékonyoldószerrel elegyedik, tangenciálisan bevezetik egy hengereskeverőkamrába, amelynek axiális kiömlőnyílása van, hogy az említettáramok örvény képződése révén bensőségesen elkeveredjenek, és az anyagkristályos részecskéi ezáltal kicsapódjanak. A keletkező kristályosrészecskéket, amelyek a keverőkamra kiömlőnyílásán távozófolyadékáramban vannak szuszpendálva, összegyűjtik. A találmány tárgyatovábbá berendezés inhalációs terápiában alkalmazható anyag kristályosrészecskéinek előállítására, a találmány szerinti eljárássalelőállítható részecskepopuláció, valamint a részecskepopulációttartalmazó por és aeroszol alakú gyógyszerkészítmény. Ó
HU0203278A 1999-11-03 2000-11-03 Apparatus and process for preparing crystalline particles HUP0203278A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9925934.3A GB9925934D0 (en) 1999-11-03 1999-11-03 Novel apparatus and process
GBGB0024511.8A GB0024511D0 (en) 1999-11-03 2000-10-06 Novel apparatus and process
PCT/GB2000/004237 WO2001032125A2 (en) 1999-11-03 2000-11-03 Apparatus and process for preparing crystalline particles

Publications (2)

Publication Number Publication Date
HUP0203278A2 true HUP0203278A2 (hu) 2003-01-28
HUP0203278A3 HUP0203278A3 (en) 2004-06-28

Family

ID=10863815

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203278A HUP0203278A3 (en) 1999-11-03 2000-11-03 Apparatus and process for preparing crystalline particles

Country Status (25)

Country Link
EP (2) EP1225875B1 (hu)
JP (1) JP4700247B2 (hu)
KR (1) KR20020047322A (hu)
CN (1) CN1409627A (hu)
AT (1) ATE271853T1 (hu)
AU (1) AU768915B2 (hu)
BR (1) BR0015271A (hu)
CA (1) CA2389908A1 (hu)
CZ (1) CZ20021555A3 (hu)
DE (1) DE60012558T2 (hu)
DK (1) DK1225875T3 (hu)
ES (1) ES2225247T3 (hu)
GB (2) GB9925934D0 (hu)
HK (1) HK1045268B (hu)
HU (1) HUP0203278A3 (hu)
IL (1) IL149366A0 (hu)
MX (1) MXPA02004394A (hu)
NO (1) NO20022059L (hu)
NZ (1) NZ518565A (hu)
PL (1) PL356746A1 (hu)
PT (1) PT1225875E (hu)
SI (1) SI1225875T1 (hu)
TR (1) TR200402709T4 (hu)
WO (1) WO2001032125A2 (hu)
ZA (1) ZA200203434B (hu)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314082T3 (es) 2001-08-02 2009-03-16 Lg Life Sciences Limited Procedimientos para la produccion de derivados amino protegidos de 4-aminometilenpirrolidin-3-ona, gemifloxacina y sus sales.
EP1423096B1 (en) * 2001-08-29 2006-08-16 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0202564D0 (en) * 2002-02-04 2002-03-20 Glaxo Group Ltd Process
JP3691459B2 (ja) * 2002-06-14 2005-09-07 久光メディカル株式会社 粉末状吸入剤組成物
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0300427D0 (en) * 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
PT1610878E (pt) * 2003-02-21 2014-12-03 Univ Bath Processo para a produção de partículas
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
CA2517727C (en) * 2003-03-04 2012-09-04 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization device and process
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
AU2004258971A1 (en) * 2003-07-22 2005-02-03 Baxter Healthcare S.A. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
JP4922762B2 (ja) 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
WO2006045795A2 (en) * 2004-10-29 2006-05-04 Akzo Nobel N.V. Processes involving the use of antisolvent crystallization
US20090259038A1 (en) * 2004-12-08 2009-10-15 Kuraray Co., Ltd. Process for producing (5alpha7alpha)-3-spiro-2'-(1',3'-dioxolan)-24-oxocholest-22-en-7-yl benzoate
KR20070119631A (ko) 2005-02-10 2007-12-20 글락소 그룹 리미티드 사전-분류 기술을 이용한 락토오스 제조 공정 및 이로부터제조된 약제 제형
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
EP2116264B1 (en) 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
GB0724498D0 (en) 2007-12-15 2008-01-30 Univ Strathclyde Slow release compositions
CN102149437B (zh) * 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
US10370402B2 (en) * 2011-07-08 2019-08-06 Pfizer Limited Process for the preparation of fluticasone propionate form 1
CN102366405A (zh) * 2011-10-21 2012-03-07 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的氟替卡松丙酸酯气雾剂制剂
DK3181122T3 (da) * 2012-01-13 2023-06-06 Xspray Pharma Ab Publ Farmaceutisk dasatinib-sammensætning
MX361886B (es) 2012-05-08 2018-12-18 Nicox Ophthalmics Inc Preparaciones de agentes terapéuticos hidrófobos, métodos de elaboración y uso de los mismos.
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
MX2015015150A (es) * 2013-04-29 2016-02-18 Sanofi Sa Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
PT108368B (pt) * 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
PT108885B (pt) * 2015-10-12 2019-02-13 Hovione Farm S A Método de produção de partículas compósitas inaláveis mediante a utilização de um atomizador de três fluidos
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN110960504A (zh) * 2019-10-31 2020-04-07 上海新黄河制药有限公司 中空颗粒制备方法及干粉吸入制剂
BR112023004247A2 (pt) * 2020-09-08 2023-04-11 Genentech Inc Kits de tubulação para formar uma mistura, sistemas para formar uma composição farmacêutica, métodos para transferir composições farmacêuticas e para fabricar uma composição farmacêutica e amortecedor de pulsação
CN112755301B (zh) * 2021-01-20 2022-03-29 孙洪坤 一种血液病造血干细胞移植用皮肤清洁器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404749D0 (en) 1984-02-23 1984-03-28 Atomic Energy Authority Uk Fluidic contactor
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4826589A (en) * 1988-06-30 1989-05-02 Gene Hirs Bar screen filter
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB9007027D0 (en) 1990-03-29 1990-05-30 Atomic Energy Authority Uk Precipitation apparatus and method
GB9101967D0 (en) 1991-01-30 1991-03-13 Atomic Energy Authority Uk Reagent mixing
GB9320455D0 (en) 1993-10-05 1993-11-24 Atomic Energy Authority Uk Vortex mixer
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations

Also Published As

Publication number Publication date
TR200402709T4 (tr) 2004-11-22
AU768915B2 (en) 2004-01-08
GB0024511D0 (en) 2000-11-22
CZ20021555A3 (cs) 2002-11-13
BR0015271A (pt) 2002-12-31
WO2001032125A3 (en) 2002-05-16
EP1225875A2 (en) 2002-07-31
MXPA02004394A (es) 2002-09-02
EP1466595A1 (en) 2004-10-13
PT1225875E (pt) 2004-12-31
GB9925934D0 (en) 1999-12-29
KR20020047322A (ko) 2002-06-21
WO2001032125A2 (en) 2001-05-10
DE60012558T2 (de) 2005-07-28
ZA200203434B (en) 2003-02-25
CA2389908A1 (en) 2001-05-10
JP2003512892A (ja) 2003-04-08
IL149366A0 (en) 2002-11-10
HUP0203278A3 (en) 2004-06-28
ES2225247T3 (es) 2005-03-16
NO20022059L (no) 2002-06-14
HK1045268B (zh) 2005-02-18
DE60012558D1 (de) 2004-09-02
PL356746A1 (en) 2004-06-28
CN1409627A (zh) 2003-04-09
NO20022059D0 (no) 2002-04-30
DK1225875T3 (da) 2004-11-22
SI1225875T1 (en) 2004-12-31
ATE271853T1 (de) 2004-08-15
JP4700247B2 (ja) 2011-06-15
AU1160401A (en) 2001-05-14
NZ518565A (en) 2004-04-30
EP1225875B1 (en) 2004-07-28
HK1045268A1 (en) 2002-11-22

Similar Documents

Publication Publication Date Title
HUP0203278A2 (hu) Új berendezés és eljárás kristályos részecskék előállítására
JP3386470B2 (ja) 粒子の形成のための方法及び装置
EP0961651B1 (en) Method & apparatus for the formation of particles
KR840000226A (ko) 신규한 형태의 의약품의 제조방법
MY117344A (en) Process for the preparation of respirable particles.
HUP0004821A2 (hu) Lágy pellet alakjában lévő gyógyszerkészítmény és előállítása
JPS638083B2 (hu)
MX2012005091A (es) Reactor para producir particulas farmaceuticas en un procedimiento de precipitacion.
HUP0000841A2 (hu) Budesonidot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma és eljárás előállítására
RU94033357A (ru) Способ и устройство для получения дискретных агломераций веществ, состоящих из микрочастиц
ATE336231T1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
MY102504A (en) Process for the production of spherical particles
ZA200405143B (en) Apparatus and process for preparing crystalline particles.
WO1999031141A3 (de) Verfahren zur herstellung von regulären porösen perlcellulosen, die perlcellulosen und ihre verwendung
ATE172695T1 (de) Verfahren zur herstellung von pulvern und suspensionen von amorphen siliziumdioxidmikrokugeln
HUP0000755A2 (hu) Terbutalin-szulfátot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma, eljárás előállítására és alkalmazása
JP2003518997A (ja) 微細粒子を捕集およびカプセル化する方法
DE60100389D1 (de) Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
US10815128B2 (en) Nanoparticles and method for producing uniform silicate-based nanoparticles
US20020189454A1 (en) Method for capturing fine particles by percolation in a bed of granules
US5030278A (en) Process of restructuring a group of finely divided particles
JPH0454511B2 (hu)
Wang Investigations in Formation and Properties of Spray-Dried Microparticles using Monodisperse Spray Drying
TH50177A (th) สารผสมชนิดใหม่ของสารซึ่งมีลักษณะเฉพาะอย่าง
RU2497758C2 (ru) Способ подготовки кремнийсодержащих растворов к переработке